ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,127.79
      1.26%
      US Tech 100
      17,446.00
      2.17%
      Dow Jones
      38,675.68
      1.18%
      Brent Oil
      82.765
      0.00%
      Bitcoin
      63,514.43
      0.99%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. USOTC
      6. BioNexus Gene Lab Corporation (PK) (BGLC)

      7. BioNexus Gene Lab Corporation (PK) (BGLC) News

      BGLC

      BioNexus Gene Lab (PK) (BGLC)

      BioNexus Gene Lab Corporation (PK)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:USOTC:BGLC
      DateTimeSourceHeadlineSymbolCompany
      04/18/20241:44PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:BGLCBioNexus Gene Lab Corporation (PK)
      04/16/20241:00PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]USOTC:BGLCBioNexus Gene Lab Corporation (PK)
      04/01/20243:59PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:BGLCBioNexus Gene Lab Corporation (PK)
      03/28/20243:59PMEdgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405USOTC:BGLCBioNexus Gene Lab Corporation (PK)
      03/26/20243:59PMEdgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]USOTC:BGLCBioNexus Gene Lab Corporation (PK)
      02/29/20245:16PMEdgar (US Regulatory)Form DEF 14C - Other definitive information statementsUSOTC:BGLCBioNexus Gene Lab Corporation (PK)
      11/20/20235:10PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:BGLCBioNexus Gene Lab Corporation (PK)
      11/14/202311:54AMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:BGLCBioNexus Gene Lab Corporation (PK)
      11/13/20231:40PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:BGLCBioNexus Gene Lab Corporation (PK)
      10/30/202312:14PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]USOTC:BGLCBioNexus Gene Lab Corporation (PK)
      10/17/202311:46AMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsUSOTC:BGLCBioNexus Gene Lab Corporation (PK)
      10/16/202310:04AMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:BGLCBioNexus Gene Lab Corporation (PK)
      10/11/202310:02AMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:BGLCBioNexus Gene Lab Corporation (PK)
      10/04/20233:57PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:BGLCBioNexus Gene Lab Corporation (PK)
      10/04/20233:57PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:BGLCBioNexus Gene Lab Corporation (PK)
      10/04/20233:57PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:BGLCBioNexus Gene Lab Corporation (PK)
      10/04/20233:56PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:BGLCBioNexus Gene Lab Corporation (PK)
      10/04/20233:56PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:BGLCBioNexus Gene Lab Corporation (PK)
      10/04/20233:56PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:BGLCBioNexus Gene Lab Corporation (PK)
      10/04/20233:55PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:BGLCBioNexus Gene Lab Corporation (PK)
      10/04/20233:55PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:BGLCBioNexus Gene Lab Corporation (PK)
      10/04/20233:55PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:BGLCBioNexus Gene Lab Corporation (PK)
      10/04/20233:54PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:BGLCBioNexus Gene Lab Corporation (PK)
      08/16/202311:26AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:BGLCBioNexus Gene Lab Corporation (PK)
      08/14/202311:55AMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:BGLCBioNexus Gene Lab Corporation (PK)
      07/21/20233:37PMEdgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]USOTC:BGLCBioNexus Gene Lab Corporation (PK)
      07/20/202312:28PMEdgar (US Regulatory)Form CERT - Certification by an exchange approving securities for listingUSOTC:BGLCBioNexus Gene Lab Corporation (PK)
      07/20/202311:29AMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:BGLCBioNexus Gene Lab Corporation (PK)
      07/20/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessUSOTC:BGLCBioNexus Gene Lab Corporation (PK)
      07/19/20232:35PMEdgar (US Regulatory)Form 8-A12B - Registration of securities [Section 12(b)]USOTC:BGLCBioNexus Gene Lab Corporation (PK)
       Showing the most relevant articles for your search:USOTC:BGLC